Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles

Therapeutic options for amyotrophic lateral sclerosis (ALS) are still limited. Great hopes, however, are placed in growth factors that show neuroprotective abilities (e.g., nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF)) and in the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Sobuś, Anna, Baumert, Bartłomiej, Litwińska, Zofia, Gołąb-Janowska, Monika, Stępniewski, Jacek, Kotowski, Maciej, Pius-Sadowska, Ewa, Kawa, Miłosz P., Gródecka-Szwajkiewicz, Dorota, Peregud-Pogorzelski, Jarosław, Dulak, Józef, Nowacki, Przemysław, Machaliński, Bogusław
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5983708/
https://ncbi.nlm.nih.gov/pubmed/29702606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19051312
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares